A clinical trial to study the effect of two drug, erand patranal kshar and salicylic acid on patients having wart.

Open Randomized Controlled Trial On Erand Patranal Kshar On Mashak With Special Reference to Wart - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062468

Enrollment

Registered

2024-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the study. 2. Patients having age between 20-70 years will be considered. 3. Patients will be selected irrespective of sex, marital status, educational status. 4. Patients having warts anywhere on the body. 5. Patients having multiple warts. 6. Planter warts, periungual warts, filiform warts, genital warts, common warts. 7. Patients with controlled diabetis mellitus (HbA1C <6).

Exclusion criteria

Exclusion criteria: 1. Mucosal warts. 2. Anaemic patients (Hb 3. Diabetic patients (uncontrolled). 4. Warts present near the periorbital region. 5. Patients with major uncontrolled illness. 6. Non-cooperative patients. 7. Immuno-compromised patients.

Design outcomes

Secondary

Measure	Time frame
To evaluate the efficacy of salicylic acid in the management of MashakTimepoint: 7 days	—

Primary

Measure	Time frame
To evaluate the efficacy of erand patranal kshar in the management of mashak.Timepoint: 7 days	—

Countries

India

Contacts

Public ContactAkash vijay chavhan

Government ayurved college and hospital, nagpur

drsyraut@yahoo.co.in9422108928

Outcome results